Publications by authors named "Marlee Muilenburg"

Claim this Profile
C
Calcineurin and mTOR Inhibitor-Free Post-Transplantation Cyclophosphamide and Bortezomib Combination for Graft-versus-Host Disease Prevention after Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I/II Study.
A Samer Al-Homsi, Kelli Cole, Marlee Muilenburg, Austin Goodyke, Muneer Abidi

Biol Blood Marrow Transplant· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib suppresses human dendritic cell and modulates murine graft-versus-host disease in a schedule-dependent fashion.
Ahmad Samer Al-Homsi, Austin Goodyke, Kelli Cole, Marlee Muilenburg, Michael McLane

Exp Hematol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone.
Ahmad Samer Al-Homsi, Austin Goodyke, Michael McLane, Sarah Abdel-Mageed, Kelli Cole, Marlee Muilenburg

Biol Blood Marrow Transplant· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib for the prevention and treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Ahmad Samer Al-Homsi, Yuxin Feng, Ulrich Duffner, Monzr M Al Malki, Austin Goodyke, Marlee Muilenburg

Exp Hematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis